Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 12, Issue 3
1 February 2006
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265

The Biology Behind

Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage
F. Stephen Hodi
View articletitled, Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage
Open the PDF for in another window

Review

Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway
Courtney A. Granville; Regan M. Memmott; Joell J. Gills; Phillip A. Dennis
View articletitled, Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway
Open the PDF for in another window

Human Cancer Biology

Expression Profiling of Mucinous Tumors of the Ovary Identifies Genes of Clinicopathologic Importance
Fred W. Wamunyokoli; Tomas Bonome; Ji-Young Lee; Colleen M. Feltmate; William R. Welch; Mike Radonovich; Cindy Pise-Masison; John Brady; Ke Hao; Ross S. Berkowitz; Samuel Mok; Michael J. Birrer
View articletitled, Expression Profiling of Mucinous Tumors of the Ovary Identifies Genes of Clinicopathologic Importance
Supplementary data
Open the PDF for in another window
Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma
Robbert J.C. Slebos; Yajun Yi; Kim Ely; Jesse Carter; Amy Evjen; Xueqiong Zhang; Yu Shyr; Barbara M. Murphy; Anthony J. Cmelak; Brian B. Burkey; James L. Netterville; Shawn Levy; Wendell G. Yarbrough; Christine H. Chung
View articletitled, Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma
Supplementary data
Open the PDF for in another window
Molecular Context of the EGFR Mutations: Evidence for the Activation of mTOR/S6K Signaling
Esther Conde; Barbara Angulo; Moying Tang; Manuel Morente; Juan Torres-Lanzas; Angel Lopez-Encuentra; Fernando Lopez-Rios; Montserrat Sanchez-Cespedes
View articletitled, Molecular Context of the <em>EGFR</em> Mutations: Evidence for the Activation of mTOR/S6K Signaling
Open the PDF for in another window
Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma
Julia S. Schleypen; Nicole Baur; Robert Kammerer; Peter J. Nelson; Karl Rohrmann; Elisabeth F. Gröne; Markus Hohenfellner; Axel Haferkamp; Heike Pohla; Dolores J. Schendel; Christine S. Falk; Elfriede Noessner
View articletitled, Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma
Open the PDF for in another window
ZAP-70 Expression in Normal Pro/Pre B Cells, Mature B Cells, and in B-Cell Acute Lymphoblastic Leukemia
Marta Crespo; Neus Villamor; Eva Giné; Ana Muntañola; Dolors Colomer; Teresa Marafioti; Margaret Jones; Mireia Camós; Elias Campo; Emili Montserrat; Francesc Bosch
View articletitled, ZAP-70 Expression in Normal Pro/Pre B Cells, Mature B Cells, and in B-Cell Acute Lymphoblastic Leukemia
Open the PDF for in another window
Homeodomain-Interacting Protein Kinase-2 Restrains Cytosolic Phospholipase A2–Dependent Prostaglandin E2 Generation in Human Colorectal Cancer Cells
Gabriella D'Orazi; Maria Gina Sciulli; Valeria Di Stefano; Sabrina Riccioni; Milo Frattini; Rita Falcioni; Lucio Bertario; Ada Sacchi; Paola Patrignani
View articletitled, Homeodomain-Interacting Protein Kinase-2 Restrains Cytosolic Phospholipase A<sub>2</sub>–Dependent Prostaglandin E<sub>2</sub> Generation in Human Colorectal Cancer Cells
Open the PDF for in another window
Purification and Characterization of Human Kallikrein 11, a Candidate Prostate and Ovarian Cancer Biomarker, from Seminal Plasma
Liu-Ying Luo; Shannon J.C. Shan; Marc B. Elliott; Antoninus Soosaipillai; Eleftherios P. Diamandis
View articletitled, Purification and Characterization of Human Kallikrein 11, a Candidate Prostate and Ovarian Cancer Biomarker, from Seminal Plasma
Open the PDF for in another window
A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening
Pasi A. Jänne; Ana M. Borras; Yanan Kuang; Andrew M. Rogers; Victoria A. Joshi; Hema Liyanage; Neal Lindeman; Jeffrey C. Lee; Balazs Halmos; Elizabeth A. Maher; Robert J. Distel; Matthew Meyerson; Bruce E. Johnson
View articletitled, A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening
Open the PDF for in another window

Imaging, Diagnosis, Prognosis

The GNAS1 T393C Polymorphism Predicts Survival in Patients with Clear Cell Renal Cell Carcinoma
Ulrich H. Frey; Gerd Lümmen; Tobias Jäger; Karl-Heinz Jöckel; Kurt W. Schmid; Herbert Rübben; Norbert Müller; Winfried Siffert; Andreas Eisenhardt
View articletitled, The <em>GNAS1</em> T393C Polymorphism Predicts Survival in Patients with Clear Cell Renal Cell Carcinoma
Open the PDF for in another window
Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage
Catherine Barrow; Judy Browning; Duncan MacGregor; Ian D. Davis; Sue Sturrock; Achim A. Jungbluth; Jonathan Cebon
View articletitled, Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage
Open the PDF for in another window
The Cytogenetic Relationship between Primary and Recurrent Meningiomas Points to the Need for New Treatment Strategies in Cases at High Risk of Relapse
Ana Belén Espinosa; María Dolores Tabernero; Angel Maíllo; José María Sayagués; Juana Ciudad; Marta Merino; Maria Carmen Alguero; Anne Marie Lubombo; Pablo Sousa; Angel Santos-Briz; Alberto Orfao
View articletitled, The Cytogenetic Relationship between Primary and Recurrent Meningiomas Points to the Need for New Treatment Strategies in Cases at High Risk of Relapse
Open the PDF for in another window
Molecular Subtyping of Breast Cancer from Traditional Tumor Marker Profiles Using Parallel Clustering Methods
Federico Ambrogi; Elia Biganzoli; Patrizia Querzoli; Stefano Ferretti; Patrizia Boracchi; Saverio Alberti; Ettore Marubini; Italo Nenci
View articletitled, Molecular Subtyping of Breast Cancer from Traditional Tumor Marker Profiles Using Parallel Clustering Methods
Open the PDF for in another window
Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling
Ben Davidson; Virginia Espina; Seth M. Steinberg; Vivi Ann Flørenes; Lance A. Liotta; Gunnar B. Kristensen; Claes G. Tropé; Aasmund Berner; Elise C. Kohn
View articletitled, Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling
Supplementary data
Open the PDF for in another window
Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D
Yasuyoshi Miyata; Shigeru Kanda; Kojiro Ohba; Koichiro Nomata; Yasushi Hayashida; Jiro Eguchi; Tomayoshi Hayashi; Hiroshi Kanetake
View articletitled, Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D
Open the PDF for in another window
Plasma Levels of Trefoil Factors are Increased in Patients with Advanced Prostate Cancer
Else Marie Vestergaard; Michael Borre; Steen Seier Poulsen; Ebba Nexø; Niels Tørring
View articletitled, Plasma Levels of Trefoil Factors are Increased in Patients with Advanced Prostate Cancer
Supplementary data
Open the PDF for in another window
Optical Coherence Tomography: Real-time Imaging of Bronchial Airways Microstructure and Detection of Inflammatory/Neoplastic Morphologic Changes
Suzanne C. Whiteman; Ying Yang; Daniel Gey van Pittius; Mark Stephens; Jitendra Parmer; Monica A. Spiteri
View articletitled, Optical Coherence Tomography: Real-time Imaging of Bronchial Airways Microstructure and Detection of Inflammatory/Neoplastic Morphologic Changes
Open the PDF for in another window
Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy
Holly K. Dressman; Christopher Hans; Andrea Bild; John A. Olson; Eric Rosen; P. Kelly Marcom; Vlayka B. Liotcheva; Ellen L. Jones; Zeljko Vujaskovic; Jeffrey Marks; Mark W. Dewhirst; Mike West; Joseph R. Nevins; Kimberly Blackwell
View articletitled, Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy
Supplementary data
Open the PDF for in another window
Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma
M. Jim Yen; Chih-Yi Hsu; Tsui-Lien Mao; T-C. Wu; Richard Roden; Tian-Li Wang; Ie-Ming Shih
View articletitled, Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma
Open the PDF for in another window

Cancer Therapy: Clinical

A Phase II Trial of Pemetrexed in Advanced Breast Cancer: Clinical Response and Association with Molecular Target Expression
Henry L. Gomez; Sergio L. Santillana; Carlos S. Vallejos; Raul Velarde; Juvenal Sanchez; Xinpeng Wang; Nancy L. Bauer; Richard D. Hockett; Victor J. Chen; Clet Niyikiza; Axel R. Hanauske
View articletitled, A Phase II Trial of Pemetrexed in Advanced Breast Cancer: Clinical Response and Association with Molecular Target Expression
Open the PDF for in another window
Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib
Gregory J. Riely; William Pao; DuyKhanh Pham; Allan R. Li; Naiyer Rizvi; Ennapadam S. Venkatraman; Maureen F. Zakowski; Mark G. Kris; Marc Ladanyi; Vincent A. Miller
View articletitled, Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib
Open the PDF for in another window
Herceptin Sensitizes ErbB2–Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 Expression
Elizabeth S. Henson; Xiaojie Hu; Spencer B. Gibson
View articletitled, Herceptin Sensitizes ErbB2–Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 Expression
Open the PDF for in another window
mdr-1 Single Nucleotide Polymorphisms in Ovarian Cancer Tissue: G2677T/A Correlates with Response to Paclitaxel Chemotherapy
Henrik Gréen; Peter Söderkvist; Per Rosenberg; György Horvath; Curt Peterson
View articletitled, <em>mdr-1</em> Single Nucleotide Polymorphisms in Ovarian Cancer Tissue: G2677T/A Correlates with Response to Paclitaxel Chemotherapy
Open the PDF for in another window
Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma
David A. Reardon; Jennifer A. Quinn; James J. Vredenburgh; Sridharan Gururangan; Allan H. Friedman; Annick Desjardins; Sith Sathornsumetee; James E. Herndon, II; Jeannette M. Dowell; Roger E. McLendon; James M. Provenzale; John H. Sampson; Robert P. Smith; Alan J. Swaisland; Judith S. Ochs; Peggy Lyons; Sandy Tourt-Uhlig; Darell D. Bigner; Henry S. Friedman; Jeremy N. Rich
View articletitled, Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma
Open the PDF for in another window
Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma
Bruce E. Loveland; Anne Zhao; Shane White; Hui Gan; Kate Hamilton; Pei-Xiang Xing; Geoffrey A. Pietersz; Vasso Apostolopoulos; Hilary Vaughan; Vaios Karanikas; Peter Kyriakou; Ian F.C. McKenzie; Paul L.R. Mitchell
View articletitled, Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma
Open the PDF for in another window
Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer
Scott J. Antonia; Noweeda Mirza; Ingo Fricke; Alberto Chiappori; Patricia Thompson; Nicholas Williams; Gerold Bepler; George Simon; William Janssen; Ji-Hyun Lee; Kerstin Menander; Sunil Chada; Dmitry I. Gabrilovich
View articletitled, Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer
Open the PDF for in another window
A Metabolic Study of Patients with Lung Cancer and Hyponatremia of Malignancy
John P. Chute; Elizabeth Taylor; John Williams; Frederic Kaye; David Venzon; Bruce E. Johnson
View articletitled, A Metabolic Study of Patients with Lung Cancer and Hyponatremia of Malignancy
Open the PDF for in another window

Cancer Therapy: Preclinical

213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model
Jeffrey P. Norenberg; Boudewijn J. Krenning; Inge R.H.M. Konings; Donna F. Kusewitt; Tapan K. Nayak; Tamara L. Anderson; Marion de Jong; Kayhan Garmestani; Martin W. Brechbiel; Larry K. Kvols
View articletitled, <sup>213</sup>Bi-[DOTA<sup>0</sup>, Tyr<sup>3</sup>]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model
Open the PDF for in another window
Strategies for Delaying or Treating In vivo Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts
Jeanne M. du Manoir; Giulio Francia; Shan Man; Miriam Mossoba; Jeffrey A. Medin; Alicia Viloria-Petit; Daniel J. Hicklin; Urban Emmenegger; Robert S. Kerbel
View articletitled, Strategies for Delaying or Treating <em>In vivo</em> Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts
Open the PDF for in another window
Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic Implications
Bin Chen; Brian W. Pogue; Jorge M. Luna; Rulon L. Hardman; P. Jack Hoopes; Tayyaba Hasan
View articletitled, Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic Implications
Open the PDF for in another window
The Schedule-Dependent Effects of the Novel Antifolate Pralatrexate and Gemcitabine Are Superior to Methotrexate and Cytarabine in Models of Human Non-Hodgkin's Lymphoma
Lorraine E. Toner; Radovan Vrhovac; Emily A. Smith; Jeffrey Gardner; Mark Heaney; Mithat Gonen; Julie Teruya-Feldstein; Frank Sirotnak; Owen A. O'Connor
View articletitled, The Schedule-Dependent Effects of the Novel Antifolate Pralatrexate and Gemcitabine Are Superior to Methotrexate and Cytarabine in Models of Human Non-Hodgkin's Lymphoma
Open the PDF for in another window
Lovastatin Protects Human Endothelial Cells from Killing by Ionizing Radiation without Impairing Induction and Repair of DNA Double-Strand Breaks
Tobias Nübel; Julia Damrot; Wynand P. Roos; Bernd Kaina; Gerhard Fritz
View articletitled, Lovastatin Protects Human Endothelial Cells from Killing by Ionizing Radiation without Impairing Induction and Repair of DNA Double-Strand Breaks
Open the PDF for in another window
Histone Deacetylase Inhibitor–Mediated Radiosensitization of Human Cancer Cells: Class Differences and the Potential Influence of p53
In Ah Kim; Jin Hee Shin; Il Han Kim; Jin Ho Kim; Jae Sung Kim; Hong Gyun Wu; Eui Kyu Chie; Sung Whan Ha; Charn Il Park; Gary D. Kao
View articletitled, Histone Deacetylase Inhibitor–Mediated Radiosensitization of Human Cancer Cells: Class Differences and the Potential Influence of p53
Supplementary data
Open the PDF for in another window
BMS-345541 Targets Inhibitor of κB Kinase and Induces Apoptosis in Melanoma: Involvement of Nuclear Factor κB and Mitochondria Pathways
Jinming Yang; Katayoun I. Amiri; James R. Burke; Johannes A. Schmid; Ann Richmond
View articletitled, BMS-345541 Targets Inhibitor of κB Kinase and Induces Apoptosis in Melanoma: Involvement of Nuclear Factor κB and Mitochondria Pathways
Open the PDF for in another window

Cancer Prevention

Risk Stratification of Colon Carcinogenesis through Enhanced Backscattering Spectroscopy Analysis of the Uninvolved Colonic Mucosa
Hemant K. Roy; Young L. Kim; Yang Liu; Ramesh K. Wali; Michael J. Goldberg; Vladimir Turzhitsky; Jonathan Horwitz; Vadim Backman
View articletitled, Risk Stratification of Colon Carcinogenesis through Enhanced Backscattering Spectroscopy Analysis of the Uninvolved Colonic Mucosa
Open the PDF for in another window
Chemoprevention of Skin Carcinogenesis by Phenylretinamides: Retinoid Receptor–Independent Tumor Suppression
Hui Xu; Satish Cheepala; Elisabeth McCauley; Kevin Coombes; Lianchun Xiao; Susan M. Fischer; John L. Clifford
View articletitled, Chemoprevention of Skin Carcinogenesis by Phenylretinamides: Retinoid Receptor–Independent Tumor Suppression
Open the PDF for in another window
2-Methoxyestradiol Inhibits Prostate Tumor Development in Transgenic Adenocarcinoma of Mouse Prostate: Role of Tumor Necrosis Factor-α–Stimulated Gene 6
Gretchen E. Garcia; Hans-Georg Wisniewski; M. Scott Lucia; Nicole Arevalo; Thomas J. Slaga; Susan L. Kraft; Robert Strange; Addanki P. Kumar
View articletitled, 2-Methoxyestradiol Inhibits Prostate Tumor Development in Transgenic Adenocarcinoma of Mouse Prostate: Role of Tumor Necrosis Factor-α–Stimulated Gene 6
Open the PDF for in another window
High Levels of Aberrant DNA Methylation in Helicobacter pylori–Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk
Takao Maekita; Kazuyuki Nakazawa; Mami Mihara; Takeshi Nakajima; Kimihiko Yanaoka; Mikitaka Iguchi; Kenji Arii; Atsushi Kaneda; Tetsuya Tsukamoto; Masae Tatematsu; Gen Tamura; Daizo Saito; Takashi Sugimura; Masao Ichinose; Toshikazu Ushijima
View articletitled, High Levels of Aberrant DNA Methylation in <em>Helicobacter pylori</em>–Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk
Supplementary data
Open the PDF for in another window

Correction

Article on Quantification of Plasma β-catenin mRNA
View articletitled, Article on Quantification of Plasma β-catenin mRNA
Open the PDF for in another window

Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer

Novel Mechanisms of Resistance to Endocrine Therapy: Genomic and Nongenomic Considerations
Anupama E. Gururaj; Suresh K. Rayala; Ratna K. Vadlamudi; Rakesh Kumar
View articletitled, Novel Mechanisms of Resistance to Endocrine Therapy: Genomic and Nongenomic Considerations
Open the PDF for in another window
ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors
Incheol Shin; Todd Miller; Carlos L. Arteaga
View articletitled, ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors
Open the PDF for in another window
Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer
Hyun-Jung Kim; Xiaojiang Cui; Susan G. Hilsenbeck; Adrian V. Lee
View articletitled, Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer
Open the PDF for in another window
Methods for Gene Expression Profiling in Clinical Trials of Adjuvant Breast Cancer Therapy
Soonmyung Paik
View articletitled, Methods for Gene Expression Profiling in Clinical Trials of Adjuvant Breast Cancer Therapy
Open the PDF for in another window
Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer
Mitch Dowsett; Ian E. Smith; Steve R. Ebbs; J. Michael Dixon; Anthony Skene; Clive Griffith; Irene Boeddinghaus; Janine Salter; Simone Detre; Margaret Hills; Susan Ashley; Stephen Francis; Geraldine Walsh; Roger A'Hern
View articletitled, Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer
Open the PDF for in another window
Adjuvant Endocrine Therapy for Postmenopausal Women with Early Breast Cancer
James N. Ingle
View articletitled, Adjuvant Endocrine Therapy for Postmenopausal Women with Early Breast Cancer
Open the PDF for in another window
Anastrozole as an Adjuvant Endocrine Treatment for Postmenopausal Patients with Breast Cancer: Emerging Data
Aman U. Buzdar; Jack Cuzick
View articletitled, Anastrozole as an Adjuvant Endocrine Treatment for Postmenopausal Patients with Breast Cancer: Emerging Data
Open the PDF for in another window
Is There a Role for Adjuvant Tamoxifen in Progesterone Receptor–Positive Breast Cancer? An In silico Clinical Trial
Susan G. Hilsenbeck; C. Kent Osborne
View articletitled, Is There a Role for Adjuvant Tamoxifen in Progesterone Receptor–Positive Breast Cancer? An <em>In silico</em> Clinical Trial
Open the PDF for in another window
Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues
Timothy J. Whelan; Kathleen I. Pritchard
View articletitled, Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues
Open the PDF for in another window
Clinical Efforts to Combine Endocrine Agents with Targeted Therapies against Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2 and Mammalian Target of Rapamycin in Breast Cancer
Stephen R.D. Johnston
View articletitled, Clinical Efforts to Combine Endocrine Agents with Targeted Therapies against Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2 and Mammalian Target of Rapamycin in Breast Cancer
Open the PDF for in another window
Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: Conference Summary Statement
Steven E. Come; Aman U. Buzdar; James N. Ingle; Carlos L. Arteaga; Myles Brown; Mitch Dowsett; Susan G. Hilsenbeck; Rakesh Kumar; Stephen R.D. Johnston; Adrian V. Lee; Soonmyung Paik; Kathleen I. Pritchard; Eric P. Winer; Carol Hart
View articletitled, Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: Conference Summary Statement
Open the PDF for in another window

Advertisement

Breaking
GSK Buys Gastrointestinal-Focused Biopharma
Eli Lilly Snaps Up PI3Kα Inhibitor
$500,000 Purse Announced for TBXT Drugs
View more recent articles
Latest News
Greater Certainty of Survival Valued Over Speedier Drug Access
Keto Diet Key to Fueling CARs?
ADC for Lymphoma Elicits Near-Perfect Response Rate
View more recent articles
Research Watch
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
Glycolysis Dictates Response to Fasting-Mimicking Diet in Breast Cancer
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept